CRVS
Corvus Pharmaceuticals, Inc.stockNASDAQ
Market OpenNov 19, 2026 2:58:52 PM EST
10.09USD-0.981%(-0.10)427,212
Pre-marketNov 19, 2026 8:38:30 AM EST
10.15USD-0.393%(-0.04)
Loading…
Loading…
851.12M
Healthcare
Biotechnology
CEO
Richard Miller
HQ
Burlingame, CA, USA
Previous Close
$10.19
Beta
-0.06
52-Week High
$26.95 2026-01-23
52-Week Low
$6.39 2026-01-12
SMA 50
$10.97
SMA 200
$13.83
Avg. Vol 10D
976,130
Avg. Vol 30D
1.03M
Avg. Vol 90D
978,397
Relative Vol
0.41
84.35M
64.97M
77.03%
17,759,451
27.41%
18.85
61%/39%
41.15%
31.23%
0.2800%
400,000
57
1,998
6,040
-64.3M
-47.9M
-45.92
Nov 16, 2026
Nov 13, 2026
Nov 9, 2026
Nov 6, 2026
CRVS Profile
corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.
CRVS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 10.62 | 2026-11-12 | -4.99% | 0.637 |
| 1M | 9.65 | 2026-10-19 | +4.56% | 1.962 |
| 3M | 15.40 | 2026-08-19 | -34.48% | 1.862 |
| 6M | 11.50 | 2026-05-19 | -12.26% | 1.568 |
| 1Y | 8.90 | 2025-11-19 | +13.37% | -0.064 |
| 2Y | 8.40 | 2024-11-19 | +20.12% | — |
| 5Y | 3.50 | 2021-11-19 | +188.29% | 1.069 |
CRVS Stock Summary
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) stock price today is $10.09, and today's volume is 424,253. CRVS is down 0.981% today. The 30 day average volume is 1.03M. CRVS market cap is $851.12M with 84.35M shares outstanding.